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Introduction
The purpose of the current report is to present rules for 
optimal scoring of the K6 screening scale of non-specifi c 
psychological distress (Kessler et al., 2002, 2003), a widely-
used short scale that screens for the presence of serious 
mental illness. As described below, the K6 was developed 
for use in community epidemiological needs assessment 
surveys in the USA but has subsequently been validated 
and used in surveys in a number of other countries. 
Optimal scoring rules have never before been proposed 
for the K6. The rules proposed in the current report are 
based on analyses of representative general population 
surveys carried out in 14 countries throughout the world 
in conjunction with the World Health Organization 
(WHO) World Mental Health (WMH) Survey Initiative 
(Kessler and Üstün, 2008). The scoring rules are provided 
separately for each country to convert K6 scores into pre-
dicted probabilities of serious mental illness.
It is important to acknowledge at the outset that it is 
preferable to base such rules on clinical calibration studies 
embedded in larger epidemiological surveys whenever 
possible. However, it is not possible to carry out a new 
clinical calibration study every time a scale is used. The 
scoring rules presented here are made available with that 
reality in mind for researchers who want to use optimal 
scoring rules based on community samples in their 
countries when independent calibration is not possible. 
The samples on which the current scoring rules are based 
range from a low of 1031 in Lebanon to a high of 5692 in 
the USA. The largest sample is from New Zealand (N = 
7435), but random half-samples in New Zealand were 
administered either of two versions of the scale described 
below, so only 3705–3730 respondents received each 
version. The combined sample size across all 14 countries 
is 41 770 respondents.
Background
Dimensional scales of non-specifi c psychological distress 
have been used in community epidemiological surveys 
since the end of World War II, beginning with the 20-item 
Health Opinion Survey in the Stirling County Study 
(Leighton, 1975; MacMillan, 1957) and the 22-item 
Langner Scale in the Midtown Manhattan Study (Langner, 
1962; Srole et al., 1962). Although originally used as fi rst-
stage screens to target respondents with broadly defi ned 
emotional problems for more in-depth clinical assess-
ment, these dimensional scales came to be used without 
clinical follow-up in later surveys (e.g. Myers et al., 1975). 
Controversy regarding the appropriate cut-point for case 
thresholds on these scales in community surveys (e.g. 
Seiler, 1973) led in later surveys to scale scores being 
reported primarily in dimensional terms (e.g. means) 
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Abstract
Data are reported on the background and performance of the K6 screening 
scale for serious mental illness (SMI) in the World Health Organization (WHO) 
World Mental Health (WMH) surveys. The K6 is a six-item scale developed to 
provide a brief valid screen for Diagnostic and Statistical Manual of Mental 
Disorders 4th edition (DSM-IV) SMI based on the criteria in the US ADAMHA 
Reorganization Act. Although methodological studies have documented good 
K6 validity in a number of countries, optimal scoring rules have never been 
proposed. Such rules are presented here based on analysis of K6 data in nation-
ally or regionally representative WMH surveys in 14 countries (combined N = 
41,770 respondents). Twelve-month prevalence of DSM-IV SMI was assessed 
with the fully-structured WHO Composite International Diagnostic Inter-
view. Nested logistic regression analysis was used to generate estimates of the 
predicted probability of SMI for each respondent from K6 scores, taking into 
consideration the possibility of variable concordance as a function of respon-
dent age, gender, education, and country. Concordance, assessed by calculating 
the area under the receiver operating characteristic curve, was generally sub-
stantial (median 0.83; range 0.76–0.89; inter-quartile range 0.81–0.85). Based 
on this result, optimal scaling rules are presented for use by investigators 
working with the K6 scale in the countries studied. Copyright © 2010 John 
Wiley & Sons, Ltd.
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rather than in terms of proportions of respondents 
screening positive (e.g. Pearlin et al., 1981).
Dimensional scales continue to be widely used to 
screen for mental illness in primary care (Coyne et al., 
2001) and to assess symptom severity and treatment effec-
tiveness in clinical studies (Rush et al., 2000). However, 
infl uenced by the widely published results of the Epide-
miological Catchment Area Study, dimensional screening 
scales went out of vogue in community psychiatric epide-
miology beginning in the early 1980s (Robins and Regier, 
1991). Fully structured research diagnostic interviews 
administered by lay interviewers have become the stan-
dard measures of psychopathology in community epide-
miological surveys since that time. A number of such 
structured diagnostic interviews now exist, including the 
Diagnostic Interview Schedule (Robins et al., 1981), the 
Composite International Diagnostic Interview (CIDI) 
(Robins et al., 1988), the PRIME-MD (Spitzer et al., 1994); 
and the Mini-International Neuropsychiatric Interview 
(Sheehan et al., 1998).
We now know, based on the use of fully structured 
research diagnostic interviews in a number of large com-
munity epidemiological surveys, that up to half the 
general population meet criteria for one or more lifetime 
International Classifi cation of Diseases (ICD) or Diag-
nostic and Statistical Manual of Mental Disorders (DSM) 
disorders and up to one-fi fth carry a DSM or ICD diag-
nosis at any one point in time (Kessler et al., 2005b, 2007). 
Although the published reports of these high prevalence 
estimates were initially met with a good deal of skepti-
cism, subsequent clinical calibration studies showed that 
they are accurate (Haro et al., 2006; Kessler et al., 1998), 
but that many community cases have considerably less 
severe disorders than those of cases in treatment 
(Demyttenaere et al., 2004; Kessler et al., 2005d). The 
fi nding that clinical severity is related to treatment is, of 
course, not surprising. However, given the high propor-
tion of people in the population who meet criteria for a 
mental disorder in relation to the societal resources avail-
able for treatment, policy-oriented interpreters of the epi-
demiological evidence have called for (Regier et al., 2000), 
and in some cases created (National Advisory Mental 
Health Council, 1993), distinctions to be made between 
people with severe and less severe mental disorders in an 
effort to defi ne medical necessity for policy-planning 
purposes. For example, the US Substance Abuse and 
Mental Health Service Administration, which adminis-
ters Block Grants to States to fund public mental health 
services for low-income people who are not otherwise 
insured, limits coverage to cases defi ned as having a 
Serious Mental Illness (SMI). The criteria for SMI require 
not only a DSM diagnosis but also specifi ed indicators of 
severity that characterize fewer than one-third of the 
people in the US population who meet criteria for a 
current DSM-IV-R disorder (Kessler et al., 2005d).
Development of the K6
Dimensional measures of non-specifi c psychological dis-
tress have come to take on new importance in the context 
of this movement to distinguish community cases based 
on severity rather than purely on diagnosis. In particular, 
a number of recent large-scale community epidemiologic 
surveys have included brief screening scales to provide a 
rapid assessment of the prevalence of SMI. Included here 
are a number of large ongoing health tracking surveys 
carried out in the USA and Australia as well as large 
needs assessment surveys carried out in Europe and Asia. 
The most widely used screening scale of SMI in these 
studies is the K6 scale (Furukawa et al., 2003; Kessler 
et al., 2002, 2003), a six-question scale that was developed 
explicitly to estimate the prevalence of SMI as defi ned by 
US Public Law (PL) 102-321, the Alcohol, Drug Abuse, 
and Mental Health Administration (ADAMHA) Reorga-
nization Act. This law established a US federal Block 
Grant for states to fund Community Mental Health Ser-
vices for adults with SMI and the law required states to 
include incidence and prevalence estimates in their 
annual applications for Block Grant funds. The law also 
required the US Substance Abuse and Mental Health Ser-
vices Administration (SAMHSA) to develop an opera-
tional defi nition of SMI and to create an estimation 
methodology based on this defi nition for use by the 
states. The defi nition of SMI stipulated in PL 102-321 
requires the person to have at least one 12-month DSM 
disorder, other than a substance-use disorder, and to 
have ‘serious impairment’.
Given the importance for policy-planning purposes of 
knowing the prevalence and socio-demographic distribu-
tion of SMI in the US population for purposes of allocat-
ing Block Grant funds (which are in excess of $1 billion 
each year), the architects of all major US federal health-
tracking surveys decided to include a measure of SMI in 
their interviews shortly after the ADAMHA Reorganiza-
tion Act was published. The K6 was developed for this 
purpose to be included in the US National Health Inter-
view Survey (NHIS), a national survey of close to 50 000 
households that has been carried out on an ongoing basis 
in the USA for more than half a century (www.cdc.gov/
nchs/nhis.htm). The goal was to create a very brief (6–10 
items) scale that would provide accurate aggregate esti-
mates of SMI prevalence and correlates. Although a 
Kessler et al. K6 screening scale for SMI
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number of distress scales existed that had been used for 
many year as of the time the K6 was developed (Derogatis, 
1983; Dohrenwend et al., 1980; Gurin et al., 1960), only a 
few of them were brief enough to meet this time require-
ment (Pearlin et al., 1981; Ware and Sherbourne, 1992) 
and none was developed using modern psychometric 
methods to maximize precision in the clinical range of 
the population distribution (van der Linden and 
Hambleton, 1997). Based on these considerations, the 
decision was made to develop a new screening scale for 
use in the redesigned NHIS.
The conceptualization of this task relied importantly 
on the work of Bruce Dohrenwend and his colleagues 
(Dohrenwend et al., 1980; Link and Dohrenwend, 1980). 
Their review of screening scales of non-specifi c psycho-
logical distress showed that these scales typically include 
questions about a heterogeneous set of cognitive, behav-
ioral, emotional, and psychophysiological symptoms that 
are elevated among people with a wide range of different 
mental disorders. However, despite this heterogeneous 
content, the vast majority of the symptoms in these scales 
have high factor loadings on a fi rst principal factor. People 
with a wide range of mental disorders typically have high 
scores on this core dimension of non-specifi c distress. 
Based on this result, this core dimension of non-specifi c 
psychological distress was taken as the focus of the new 
scale. Because the requirements called for a very short 
scale, the K6 was developed using modern psychometric 
methods to select questions with the maximum precision 
at the clinical threshold of the scale. Based on the fact that 
no more than 10%, and probably closer to 6%, of the US 
population were estimated to meet criteria for SMI in a 
given year (Kessler et al., 1996), the decision was made at 
the onset to seek maximum precision around the 90th 
percentile of the general population distribution.
K6 validation studies
As detailed elsewhere (Kessler et al., 2002, 2003), indepen-
dent clinical validation studies showed that the K6 has 
very good concordance with blinded clinical diagnoses of 
SMI in general population samples from the USA. Based 
on this evidence, the other two major ongoing national 
health tracking surveys in the USA, the CDC Behavioral 
Risk Factors Surveillance Survey (www.cdc.gov/BRFSS) 
and the SAMHSA National Household Survey on Drug 
Use and Health (www.oas.samhsa.gov/nhsda.htm), both 
adopted the K6 as part of their assessment of health 
shortly thereafter. Taken together, these three ongoing US 
surveys interview representative samples of nearly 500 000 
people each year, creating the potential for making them 
the largest tracking series on the prevalence and correlates 
of SMI in the world.
Based on the adoption of the K6 by these three large 
ongoing US federal health tracking surveys, K6 validation 
studies were carried out in a number of other countries 
throughout the world (Fassaert et al., 2009; Furukawa 
et al., 2003, 2008; Gill et al., 2007; Patel et al., 2008). 
These studies uniformly found the K6 and a larger related 
scale known as the K10 (which includes the K6 in addi-
tion to four other items) to have very good concordance 
with independent clinical ratings of SMI. These studies 
also found, consistent with results in the USA, that the 
K6 performed as well as the K10, leading to the recom-
mendation that the six-item version be used rather than 
the 10-item version. Additional studies found similarly 
good concordance in special patient populations that 
included primary-care attenders (Haller et al., 2009), 
postnatal females (Baggaley et al., 2007; Tesfaye et al., 
2009), and patients with substance-use disorders (Hides 
et al., 2007; Swartz and Lurigio, 2006). Methodological 
research also showed that the K6 has little bias with 
regard to sex and education (Baillie, 2005), a feature that 
was built into the scale from the outset, as items were 
selected for the K6 based on formal comparisons of age, 
sex, and education differences in differential item func-
tioning to minimize biases with regard to these variables 
(Kessler et al., 2002).
Alternative approaches to K6 scoring
The widespread adoption of the K6 in epidemiological 
surveys throughout the world is based on the very good 
performance of this short screening in the validity studies 
reviewed in the last paragraph. However, despite this wide 
use, no clear standards have yet emerged for optimal K6 
scoring. As each scale item has fi ve categories and there 
are six items, the unweighted scale has values in the range 
0–24. The scoring rule used in most applications based 
on standard validation studies is to classify respondents 
with scores of 13–24 as having probable SMI and those 
with scores of 0–12 as probably not having SMI (Kessler 
et al., 2003). However, Furukawa and colleagues 
(Furukawa et al., 2003, 2008) have shown that this simple 
dichotomous scoring approach can be refi ned by using 
polychotomous rather than dichotomous scoring rules 
that collapse K6 scores into strata based on analysis of 
data in a clinical calibration study such that the observed 
prevalence of SMI differs signifi cantly across strata. For 
example, one such scoring rule might collapse K6 scores 
into strata with K6 score values of 0, 1–7, 8–12, 13–18, and 
19–24, with respondents in each stratum assigned a 
K6 screening scale for SMI Kessler et al.
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predicted probability of SMI based on the results of a 
clinical calibration study.
Rather than interpret the precision of the K6 in terms 
of sensitivity (the proportion of true cases who are 
detected in the screening scale) and specifi city (the per-
centage of true non-cases who are correctly classifi ed as 
non-cases by the screening scale) based on a single diag-
nostic threshold, as in the dichotomous approach, the 
stratum-specifi c predicted probabilities generated in this 
polychotomous approach can be assigned as outcome 
variable scores and used directly for purposes of estimat-
ing prevalence and studying correlates. In other words, 
each respondent’s K6 score is transformed into a score in 
the range 0.0 to 1.0 that represents the predicted probabil-
ity of having SMI.
Furukawa and associates proposed to use the K6 in 
clinical screening to assign individual patients predicted 
scores of SMI based on the method of Stratum-Specifi c 
Likelihood Ratio (SSLR) analysis, a method that begins 
with estimates of sensitivity and specifi city for each K6 
stratum and estimates each patient’s predicted probabil-
ity of SMI based on external assumptions about preva-
lence in the population of interest (Guyatt and Rennie, 
2001). The use of this approach is based on the assump-
tion that sensitivity and specifi city are more stable across 
populations than is positive predictive value (PPV; the 
prevalence of SMI among respondents with a given K6 
score), an assumption that is widely accepted in the 
methodological literature on medical decision-making 
(Rao, 2006). When this assumption holds, PPV for given 
values of sensitivity and specifi city depends on the preva-
lence of the disorder in the population being screened, 
making it necessary either to obtain independent data 
on this prevalence or to make an informed assumption 
about this prevalence before estimating PPV from data 
on sensitivity and specifi city. The SSLR approach pro-
vides a convenient way to do this when sensitivity and 
specifi city are assumed to be known (presumably based 
on a previous clinical calibration study) and prevalence 
is estimated externally. Examples of using SSLR analysis 
in this way are reported in the literature (Furukawa 
et al., 2001, 2002).
We propose in the next paragraph a different approach 
than SSLR analysis for use in epidemiological surveys. 
However, it should be noted that it is possible to use 
maximum-likelihood methods to estimate prevalence in 
clinical situations to avoid the requirement suggested by 
Furukawa and colleagues of estimating prevalence based 
on external information. In brief, in a clinical situation 
where SSLR analysis is being used and sample data on K6 
scores are available from the clinical population from 
which an individual patient comes, a predicted 
distribution of K6 scores can be generated for every pos-
sible value of SMI prevalence based on the known (pre-
sumably from some independent clinical calibration 
sample that is assumed to apply to the population) sensi-
tivity and specifi city of each K6 score or category. The 
SMI prevalence estimate that generates a predicted K6 
distribution most closely approximating the observed 
distribution in the clinical population from which the 
patient comes is the maximum likelihood estimate of 
prevalence in that population based on the assumption 
that the sensitivity and specifi city estimates actually apply 
to that population.
The weakness of this approach is that it requires 
assumptions to be made about the values of sensitivity 
and specifi city. A preferable approach would be to embed 
a clinical calibration study in the data collection so as to 
estimate PPV directly rather than have to estimate PPV 
and prevalence based on external data using a pre-
established set of estimates of sensitivity and specifi city. 
This kind of internal clinical calibration study is a 
common feature of psychiatric epidemiological surveys 
(Haro et al., 2006; Kessler and Üstün, 2004), where a prob-
ability sub-sample of survey respondents that over-
samples screened positives is re-interviewed by clinical 
interviewers who make diagnoses blinded to the K6 scores 
in the main survey. Once data of this sort are available, 
the SSLR approach can be expanded to use K6 scores along 
with measures of other predictors of SMI, such as socio-
demographic variables, in a multiple regression analysis 
within the clinical calibration sub-sample (appropriately 
weighted to adjust for the over-sampling of respondents 
with high K6 scores) that explores both the functional 
form of the association between K6 scores and SMI and 
the possibility that this association varies as a function of 
the respondent’s age, sex, education, or other character-
istics. When a best-fi tting model is found, a predicted 
probability of SMI based on this model can be assigned 
to each sample respondent. These predicted probabilities 
can then be used to estimate prevalence and correlates of 
SMI. As noted in the introduction, the purpose of the 
current report is to present scoring rules based on such 
analyses of general population survey data obtained in the 
WHO WMH Survey Initiative (Kessler and Üstün, 2008).
Adjusting for the imprecision of estimates
In providing these transformation rules, it is important 
to recognize that the uncertainty of inference from the 
prediction equations needs to be taken into consideration 
in analysing estimates of the prevalence and correlates 
Kessler et al. K6 screening scale for SMI
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of SMI based on transformed K6 data. Conventional 
signifi cance testing would treat the individual-level pre-
dicted probabilities of SMI as known rather than 
estimated from a model. The method of multiple imputa-
tion (MI) (Rubin, 1987) can be used to overcome this 
limitation by generating a number of different estimates 
of the predicted probability of SMI for each respondent 
and using information about variation across these pre-
dictions to adjust estimates of standard errors for impre-
cision. In our use of the approach, this was done by 
estimating the fi nal prediction equation 10 times, once in 
each of 10 pseudo-samples. Each pseudo-sample con-
sisted of a random sample of respondents equal to the 
actual sample size, but selected with replacement from the 
actual sample. The with-replacement option means that 
some respondents in the actual sample were included zero 
times, others once, and others more than once in each 
pseudo-sample. The precise values of the regression coef-
fi cients varied across pseudo-samples because of this 
variation in sample composition.
The MI method requires us to make all estimates 10 
times, once in each pseudo-sample, and then to combine 
these estimates in such a way as to account both for 
between-person variation and for within-person varia-
tion. The MI parameter estimates are defi ned as the 
means across the 10 pseudo-samples of the within-sample 
estimates and the MI standard error of any given param-
eter estimate is then defi ned as the square root of the sum 
of two components. The fi rst component is the mean of 
the square of the 10 within-sample standard errors (i.e. 
the between-person variance component). The second 
component is a transformation of the variance of the 
parameter estimates across the 10 samples (i.e. the within-
person variance component). In the extreme case where 
the K6 is totally unrelated to SMI in a particular popula-
tion, the only systematic information in the multiply 
imputed dataset will be the consistent 0.0 and 1.0 values 
in the sub-sample of respondents who were in the clinical 
calibration sub-sample.
The expected value of predicted disorder prevalence 
for each respondent who was not in the clinical calibra-
tion sub-sample will be the SMI prevalence in the clinical 
calibration sub-sample. In a case of this sort, the MI pre-
dicted SMI prevalence estimate will be unbiased and the 
standard error of the estimate will be equivalent to the 
design-based standard error in the clinical calibration 
sub-sample. At the other extreme, where the K6 perfectly 
predicts SMI, the MI standard error of the SMI prevalence 
estimate will be equivalent to the design-based standard 
error in the total sample. In more realistic cases, in which 
concordance between the K6 and the clinical diagnoses is 
signifi cant but imperfect, the MI standard error will take 
into consideration both the size of the clinical calibration 
sub-sample and the strength of the association between 
the K6 and clinical diagnoses. The situation is similar for 
higher-order statistics, with the exception that measures 
of association will be biased towards zero by lack of con-
cordance between predicted and true SMI diagnoses. The 
practical use of this approach is illustrated in a more 
detailed methodological exposition published previously 
(Kessler and Üstün, 2004) as well as in a number of sub-
sequent substantive reports that used this approach to 
estimate the prevalence and correlates of several different 
DSM-IV disorders (Fayyad et al., 2007; Huang et al., 2009; 
Kessler et al., 2005c).
To allow researchers to implement this MI approach 
to estimation when they use our transformation rules to 
score K6 responses, we generated 10 pseudo-samples for 
each of the 14 countries in the WMH series and then 
estimated the coeffi cients for the best-fi tting prediction 
equation for the country (which was developed in analysis 
of the original sample rather than pseudo-samples) sepa-
rately in each of those pseudo-samples. These 10 separate 
sets of coeffi cients are provided in appendix tables for 
each of the 14 countries (available at http://www.hcp.med.
harvard.edu/wmh/publications.php). The remainder of 
the paper describes the methods used to carry out the 
analyses that selected the best-fi tting equations, presents 
descriptive statistics describing the accuracy of these 
equations, and discusses a number of special substantive 
analysis issues in working with data of the sort generated 
by these MI methods.
Methods
Samples
The WMH surveys were carried out in 14 countries in 
Africa (Nigeria, South Africa), the Americas (Brazil, 
Colombia, Mexico, USA), Asia and the Pacifi c [India, 
Japan, New Zealand, and separate surveys in Beijing, 
Shanghai, and Shenzhen in the People’s Republic of China 
(PRC), described below as Metropolitan PRC], Europe 
(Bulgaria, Romania, Ukraine), and the Middle East 
(Lebanon) (Table 1). Eleven of these countries are classi-
fi ed by the World Bank as less developed (Brazil, Bulgaria, 
China, Colombia, India, Lebanon, Mexico, Nigeria, 
Romania, South Africa, Ukraine). The others are devel-
oped. Country-level sample sizes range from a low of 1031 
(Lebanon) to a high of 5692 (US). The total sample size is 
41,770. The weighted average cross-national response rate 
was 75.5% with a range between 55.1% (Japan) and 98.8% 
(India).
K6 screening scale for SMI Kessler et al.
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Table 1 WMH Sample Characteristics









Brazil São Paulo 
Megacity
Stratifi ed multistage clustered area probability sample of household 
residents in the São Paulo metropolitan area
2005–7 18+ 2 942 81.3
Bulgaria NSHS Stratifi ed multistage clustered area probability sample of household 
residents. NR
2003–7 18+ 2 233 72.0
Colombia NSMH Stratifi ed multistage clustered area probability sample of household 
residents in all urban areas of the country (approximately 73% 
of the total national population)
2003 18–65 2 381 87.7
India WMHI Stratifi ed multistage clustered area probability sample of household 
residents in Pondicherry region. NR
2003–5 18+ 1 373 98.8
Japan WMHJ 
2002–2006
Unclustered two-stage probability sample of individuals residing in 
households in 11 metropolitan areas
2002–6 20+ 1 682 55.1
Lebanon LEBANON Stratifi ed multistage clustered area probability sample of household 
residents. NR
2002–3 18+ 1 031 70.0
Mexico M-NCS Stratifi ed multistage clustered area probability sample of household 
residents in all urban areas of the country (approximately 75% 
of the total national population)
2001–2 18–65 2 362 76.6
New Zealand5 NZMHS Stratifi ed multistage clustered area probability sample of household 
residents. NR
2004–5 18+ 7 435 73.3
Nigeria NSMHW Stratifi ed multistage clustered area probability sample of 
households in 21 of the 36 states in the country, representing 
57% of the national population. The surveys were conducted in 
Yoruba, Igbo, Hausa and Efi k languages





Stratifi ed multistage clustered area probability sample of household 
residents in the Beijing and Shanghai metropolitan areas
2002–3 18+ 1 628 74.7
People’s Republic 
of China
Shenzhen Stratifi ed multistage clustered area probability sample of household 
residents and temporary residents in the Shenzhen area
2006–7 18+ 2 476 80.0
Romania RMHS Stratifi ed multistage clustered area probability sample of household 
residents. NR
2005–6 18+ 2 357 70.9
South Africa SASH Stratifi ed multistage clustered area probability sample of household 
residents. NR
2003–4 18+ 4 315 87.1
Ukraine CMDPSD Stratifi ed multistage clustered area probability sample of household 
residents. NR
2002 18+ 1 720 78.3
United States NCS-R Stratifi ed multistage clustered area probability sample of household 
residents. NR
2002–3 18+ 5 692 70.9
Total 41 770
1 NSHS (Bulgaria National Survey of Health and Stress); NSMH (The Colombian National Study of Mental Health); WMHI (World Mental Health 
India); WMHJ 2002–2006 (World Mental Health Japan Survey); LEBANON (Lebanese Evaluation of the Burden of Ailments and Needs of the 
Nation); M-NCS (The Mexico National Comorbidity Survey); NZMHS (New Zealand Mental Health Survey); NSMHW (The Nigerian Survey of 
Mental Health and Wellbeing); B-WMH (The Beijing World Mental Health Survey); S-WMH (The Shanghai World Mental Health Survey); RMHS 
(Romania Mental Health Survey); SASH (South Africa Health Survey); CMDPSD (Comorbid Mental Disorders during Periods of Social Disruption); 
NCS-R (The US National Comorbidity Survey Replication).
2 Most WMH surveys are based on stratifi ed multistage clustered area probability household samples in which samples of areas equivalent to 
counties or municipalities in the USA were selected in the fi rst stage followed by one or more subsequent stages of geographic sampling (e.g. 
towns within counties, blocks within towns, households within blocks) to arrive at a sample of households, in each of which a listing of household 
members was created and one or two people were selected from this listing to be interviewed. No substitution was allowed when the originally 
sampled household resident could not be interviewed. These household samples were selected from census area data in all countries. The Japa-
nese sample is the only totally unclustered sample, with households randomly selected in each of the 11 sample areas and one random respondent 
selected in each sample household. Of the 15 surveys, 13 are based on nationally representative (NR) household samples, while two others are 
based on nationally representative household samples in urbanized areas (Colombia, Mexico).
3 Aa noted in the text, the WMH surveys were administered in two parts in all countries other than Romania and South Africa. The K6 was 
administered in Part 2. The full sample was administered Part 1, while Part 2 was administered to 100% of the Part 1 respondents who had a 
disorder assessed in Part 1 plus a probability sub-sample of other Part 1 respondents. The Part 2 sample was weighted to adjust for the under-
sampling of the Part 1 respondents who did not have a disorder. The sample sizes reported here are the unweighted numbers of respondents 
in the Part 2 sample.
4 The response rate is calculated as the ratio of the number of households in which an interview was completed to the number of households 
originally sampled, excluding from the denominator households known not to be eligible either because of being vacant at the time of initial 
contact or because the residents were unable to speak the designated languages of the survey. The weighted average response rate is 75.5%.
5 New Zealand interviewed respondents 16+ but for the purposes of cross-national comparisons we limit the sample to those 18+.
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All surveys were based on multi-stage geographically 
clustered area probability household samples. Interviews 
were carried out face-to-face by trained lay interviewers. 
Surveys in 10 countries were based on nationally repre-
sentative samples, while two others were based on 
nationally representative samples of urbanized areas 
(Colombia, Mexico), and the other two on regional 
samples (Brazil, PRC). Respondents had to be at least 18 
years of age in most countries (20 in Japan). Colombia 
and Mexico were the only countries with an upper age 
limit (65). Informed consent was obtained using proce-
dures approved by local Institutional Review Boards. 
Detailed descriptions of WMH sampling, recruitment, 
and consent procedures are presented elsewhere 
(Heeringa et al., 2008).
Other than in Romania and South Africa, where all 
respondents were administered the full interview, inter-
nal sub-sampling was used to reduce respondent burden 
by dividing the interview into two parts. Part 1 assessed 
core mental disorders and was administered to all respon-
dents. Part 2 included additional disorders and correlates 
and was administered to all Part 1 respondents who met 
criteria for any lifetime Part 1 disorder plus a probability 
sub-sample of other respondents. The K6 was included in 
Part 2. Part 1 data were weighted to adjust for differential 
probabilities of selection and to match population distri-
butions on census socio-demographic and geographic 
distributions. Part 2 data were additionally weighted for 
the under-sampling of Part 1 respondents without core 
disorders. WMH weighting procedures are discussed 
elsewhere (Heeringa et al., 2008).
Measures
Diagnostic assessment
Lifetime and 12-month prevalence of DSM-IV anxiety, 
mood, behavioral, and substance disorders were assessed 
using Version 3.0 of the WHO CIDI (Kessler and Üstün, 
2004), a fully structured lay-administered interview. The 
English source version of the CIDI was translated into 
other languages using standardized WHO protocols 
(Harkness et al., 2008). Rigorous interviewer training and 
quality control monitoring were used to guarantee con-
sistent administration (Pennell et al., 2008). CIDI diagno-
ses were compared with blinded clinical diagnoses using 
the Structured Clinical Interview for DSM-IV (SCID) 
(Spitzer et al., 1994) in probability sub-samples of WMH 
respondents from France, Italy, Spain, and the USA. As 
detailed elsewhere, good CIDI-SCID diagnostic concor-
dance was found for most DM-IV/CIDI disorders (Haro 
et al., 2006).
SMI
Respondents were classifi ed as having SMI in the 12 
months before interview if they met criteria for one or 
more 12-month DSM-IV/CIDI mental disorders and also 
had any of a number of indicators of severity, which 
included a 12-month suicide attempt with serious lethal-
ity of intent, work disability, or substantial limitation as 
the result of a mental disorder, bipolar I disorder, a behav-
ioral disorder with associated serious violence or criminal 
behavior, or any disorder that resulted in 30+ days out of 
role in the year. A more detailed description of the SMI 
coding scheme is presented elsewhere (Demyttenaere 
et al., 2004).
The K6
The K6 consists of six questions that ask subjects to rate 
how often they felt
1 nervous
2 hopeless
3 restless or fi dgety
4 so depressed that nothing could cheer you up
5 that everything was an effort
6 worthless over one of two recall periods: the past-
month (respondents were asked to rate how often the 
symptoms occurred in the 30 days before the survey) 
and the worst-month (respondents were asked about 
the 30-day period during the past 12 months when they 
had the most severe psychological distress).
Some WMH surveys used only one of these recall periods 
while others used both. The decision about which recall 
period to used hinged on whether the investigators were 
interested in calibrating SMI point prevalence (most 
useful for screening in clinical settings), 12-month preva-
lence (most useful for estimating prevalence in surveys 
used for health-policy planning purposes, as the year is 
the usual health-policy planning period), or both.
The surveys that used both recall periods began by 
administering the past-month questions and then asked 
respondents a single question about whether there was 
any other 30-day period in the past 12 months when they 
had had these symptoms more frequently than in the past 
30 days. If not, then the past-month responses were also 
used as the worst-month responses. However, if the 
respondents reported that there was a worst month, they 
were asked to think about that time in answering the six 
questions a second time. The six K6 questions had to be 
repeated for about 20% of respondents when this two-
part approach was used. That is, about 80% of the time 
respondents reported that there was no other 30-day 
K6 screening scale for SMI Kessler et al.
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period in the past 12 months that was worse than the last 
30 days. The response options, which were identical in the 
two recall periods, were all of the time, most of the time, 
some of the time, a little of the time, and none of the time. 
These were coded 4 to 0, which means that the unweighted 
summary scale has a 0–24 range. However, it is also pos-
sible to weight either the scale items (as in a factor analysis 
factor-weighted scale; Kim, 1993) or to weight the item 
responses within each item [as in an analysis of nested 
dichotomous items in an item response theory (IRT) 
modeling approach; Embretson and Reise, 2000].
Socio-demographics
We considered three dichotomously scored socio-
demographic variables in the analysis: gender, age (18–38, 
39+), and education (completed no more than secondary 
education, completed more than secondary education). 
All three were used to predict SMI both alone and in 
interaction with the others. Interactions of K6 scores 
were evaluated with each socio-demographic alone as well 
as with the cross-classifi cation of the full set of 
socio-demographics.
Statistical analysis
Six-by-six matrices of Pearson correlations among the K6 
item responses were created for each recall period in each 
country. Principal axis factor analysis using the factor 
procedure in SAS 9.1 (SAS Institute Inc., 1999) was carried 
out to determine if the unidimensionality found in the 
original US psychometric studies was confi rmed in each 
country in the WMH data. Parallel factor analyses were 
then carried out based on matrices of polychoric correla-
tions, which allow for non-linear monotonic relationships 
between pairs of variables. The factor analysis results 
showed that the scale is unidimensional (i.e. has a large 
fi rst unrotated eigenvalue and a second unrotated eigen-
value less than 1.0) and has factor loadings on the fi rst 
factor that are quite similar across items in both Pearson 
and polychoric matrices. This last result means that it 
would be unproductive to create a factor-weighted scale 
rather than a simple 0–24 unweighted scale.
However, polychoric correlations were generally some-
what larger than Pearson correlations, suggesting that 
meaningful non-linearities might exist in the associations 
between items. The implications of this were investigated 
by estimating IRT models using the bilog-mg program 
(Scientifi c Software International, 1996) based on nested 
dichotomous versions of the K6 items. By the term ‘nested 
dichotomies’ we mean that the 0–4 responses to each item 
were converted into four dichotomies (0 versus 1–4, 0–1 
versus 2–4, 0–2 versus 3–4, 0–3 versus 4). Unlike classical 
psychometric test theory models, the IRT models allowed 
us to capture information about the contribution of each 
item to the sensitivity of the total scale using conventional 
one-parameter and two-parameter IRT logistic regression 
models for binary scale items (van der Linden and 
Hambleton, 1997). The two-parameter model is given by:
 P Tij
a TPD be j i j( ) = +[ ]− −( ) −1 1  (1)
Where the outcome variable Pij(Ti) is the probability 
that respondent i will endorse binary item j as a function 
of his or her underlying true score (T). The slope aj mea-
sures the steepness of the logistic curve at the point where 
the probability of endorsing item j is 0.5. A steep curve 
means that the item has strong discriminating ability at 
the point on the curve where it has maximum informa-
tion value. The intercept bj is the point on the T distribu-
tion at which the probability of endorsing item j is 0.5, 
therefore representing the severity of the item. The one-
parameter model differs from the two-parameter model 
in that the parameter for the steepness of the slope is 
constrained to be constant across items. Inspection of a 
wide range of items in such models was used in the initial 
development phase to select the fi nal set of items to 
include in the K6 (Kessler et al., 2002). In the current 
application, the models were used to generate an opti-
mally weighted version of the scale in each country by 
summing the item slopes for each endorsed item. When 
the item parameters are fi xed, as they would be when 
results in a benchmarking survey are used to defi ne the 
metric of the scale in later surveys, this score is a suffi cient 
statistic for the person parameter (T).
A series of nested logistic regression equations was 
then estimated to predict SMI in each time frame in each 
country using either the unweighted or IRT-weighted ver-
sions of the K6 scale along with controls for age, sex, and 
education. The equations explored the existence of non-
linearities in the association of K6 scores with log-odds 
of SMI by including not only linear but also quadratic and 
third-degree forms of the K6 as predictors (i.e. K6, 
K6-squared, and K6-cubed all as predictors in the same 
equation). We also evaluated the signifi cant of interac-
tions between K6 scores and the socio-demographic 
variables. Model fi t was evaluated using the Akaike Infor-
mation Criterion and the Bayesian Information Criterion, 
two commonly used methods to select best-fi tting models 
(Burnham and Anderson, 2004).
Once a best-fi tting model was determined, parameters 
for that model were used to generate an estimate of the 
predicted probability of SMI for each respondent in the 
Kessler et al. K6 screening scale for SMI
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WMH survey. That variable was then compared with 
observed SMI scores using receiver operating character-
istic curve analysis (Margolis et al., 2002) and the area 
under the receiver operating characteristic curve (AUC) 
(Pepe, 2003) was calculated as a measure of concordance 
between predicted and observed SMI scores. The AUC 
can be interpreted as the probability of correctly identify-
ing a case of SMI in a series of paired comparison tests in 
which scores on the K6-tranformed predicted probability 
scale are compared between one randomly selected 
respondent with SMI and one randomly selected respon-
dent without SMI and the respondent with the higher 
score is estimated to be the one with SMI. In cases where 
the predicted probabilities of the two respondents are 
identical, the estimate of which one has SMI is based on 
random assignment. The AUC has an expected value of 
0.50 when the predicted probability is completely unre-
lated to the true SMI and an expected value of 1.0 when 
the predicted probability is perfectly related to true SMI. 
Scores between these two extremes are often interpreted 
in parallel with the interpretation of Kappa (Landis and 
Koch, 1977) as slight (0.5–0.6), fair (0.6–0.7), moderate 
(0.7–0.8), substantial (0.8–0.9), or almost perfect (0.9+).
Once the best-fi tting model was selected in each 
survey, the parameters of the best-fi tting model were esti-
mated again in each of 10 pseudo-samples selected with 
replacement from the sample in the WMH survey for the 
country. The parameter values for these 10 equations are 
presented for each recall period for each country in 
appendix tables (available at http://www.hcp.med.
harvard.edu/wmh/publications.php) that can be used by 
other investigators to convert K6 scores in their samples 
into predicted probabilities of SMI. Ten different esti-
mates are presented to allow researchers to generate 10 
different estimates of SMI in their data for use in MI 
analysis. A brief exposition of appropriate analysis 
methods in using these MI estimates is presented below 
in the Discussion section.
Results
Dimensionality and consistency of factor loadings
Exploratory factor analysis showed a strong unidimen-
sional structure in both the Pearson and polychoric cor-
relation matrices in all countries for both past-month and 
worst-month recall periods. In the case of the Pearson 
correlation matrices, the unrotated eigenvalues were in 
the range 2.0–3.8 for the fi rst factor, but were also gener-
ally greater than 1.0 for the second factor (1.2–1.5). 
However, promax rotation found no consistently inter-
pretable second factor in the Pearson data. Furthermore, 
once we adjusted for non-linearities in the polychoric 
matrices, the unrotated eigenvalues of the fi rst factor 
consistently increased (3.7–5.0) and with one exception 
the unrotated eigenvalues of the second factor became less 
than 1.0 (0.4–0.8) in both time frames (Table 2). The 
exception was in India, where the eigenvalues for the fi rst 
two factors were 4.0 and 1.2 in the past-month time frame 
and 4.2 and 1.1 in the worst-month time frame. Inspec-
tion of factor loadings for the promax rotated second 
factor found this to be a unique factor for the ‘everything 
was an effort’ item. This result was due to a very low cor-
relation (0.06 in the worst-month time frame) of the 
‘everything was an effort’ item with the ‘restless-fi dgety’ 
item and lower correlations of the ‘everything was an 
effort’ item than the ‘restless- fi dgety’ item with the other 
four items (0.32–0.61 versus 0.75–0.89).
The low correlation between the ‘everything was an 
effort’ item and the ‘restless-fi dgety’ item might be 
Table 2 Eigenvalues for fi rst two unrotated factors from 
principal axis factor analysis of the polychoric correlation 






I II I II
Brazil 4.1 0.6 4.4 0.6
Bulgaria 4.5 0.7 4.7 0.7
Colombia 4.2 0.6 4.3 0.6
India 4.0 1.2 4.2 1.1
Japan 3.9 0.7 4.4 0.6
Lebanon 3.9 0.7 – –
Mexico – – 4.8 0.5
New Zealand 4.3 0.6 4.5 0.5
Nigeria 4.2 0.6 – –
People’s Republic of China
 Beijing/Shanghai 3.9 0.8 – –
 Shenzhen 3.9 0.8 4.0 0.8
Romania 4.9 0.4 5.0 0.4
South Africa 4.1 0.7 – –
Ukraine 3.7 0.7 – –
USA – – 4.2 0.6
Total 4.2 0.6 4.4 0.6
1 Some countries used only one recall period. This is why 
there are missing values in some cells of the table. The 
results in the total row are based on analysis of pooled 
within-country matrices that weight countries by the 
number of respondents in their samples rather than by 
their population sizes.
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expected because the fi rst is associated with retarded 
symptoms and the second with agitated symptoms. 
Indeed, this correlation is generally the lowest one in both 
the Pearson and polychoric matrices across countries. 
Despite this fact, though, the factor loadings of both these 
items are acceptable in both the past-month and worst-
month time frames in all countries, including India 
(Table 3). Even in India, where ‘everything was an effort’ 
formed a separate factor, the factor loading of this item 
in the one-factor solution was acceptable (0.50). It is also 
noteworthy that variation in factor loadings was relatively 
small in all countries other than India in both the past-
month and worst-month time frames, with within-
country ranges of 0.10–0.24 (past-month) and 0.10–0.15 
(worst-month). This implies that factor-weighted scales 
would be very highly correlated with unit-weighted scales. 
We found this to be the case empirically, with Pearson 
correlations above 0.95 between the two kinds of scales in 
each country, leading us to focus on the unit-weighted 
(i.e. 0–24) scale in the remainder of the analysis.
The IRT analysis
It was noted above that the polychoric correlations were 
generally larger than the Pearson correlation, indicating 
that meaningful non-linearities exist in the associations 
among K6 items. Consistent with this observation, the IRT 
severity parameters were in most cases found to be non-
linear across the range of item responses. This was true 
both in one-parameter IRT models (i.e. models in which 
slopes were constrained to be equal across items) and in 
two-parameter IRT models (i.e. where slopes were esti-
mated separately for each item). Indeed, severity parame-
ters were very similar in one-parameter and two-parameter 
models because all slopes were excellent. In saying this, we 
note that good IRT slopes are generally considered ones 
Table 3 Unrotated factor loadings for the fi rst factor from principal axis factor analysis of the polychoric correlation 
matrix of K6 items separately for past-month (P) and worst-month (W) recall periods1
Nervous Hopeless Restless Depressed Effort Worthless
P W P W P W P W P W P W
Brazil 0.80 0.82 0.85 0.88 0.78 0.81 0.90 0.92 0.81 0.85 0.84 0.85
Bulgaria 0.75 0.80 0.91 0.93 0.81 0.82 0.93 0.94 0.91 0.92 0.87 0.87
Colombia 0.75 0.76 0.83 0.85 0.81 0.82 0.87 0.88 0.87 0.88 0.90 0.91
India 0.86 0.93 0.97 0.96 0.82 0.81 0.88 0.86 0.43 0.50 0.84 0.89
Japan 0.72 0.80 0.87 0.92 0.76 0.82 0.90 0.93 0.78 0.85 0.78 0.82
Lebanon 0.71 – 0.85 – 0.81 – 0.90 – 0.70 – 0.85 –
Mexico – 0.82 – 0.92 – 0.90 – 0.93 – 0.92 – 0.90
New Zealand 0.75 0.80 0.92 0.90 0.78 0.79 0.91 0.92 0.82 0.86 0.90 0.92
Nigeria 0.79 – 0.87 – 0.85 – 0.88 – 0.78 – 0.84 –
People’s Republic of China
 Beijing/Shanghai 0.68 – 0.85 – 0.79 – 0.92 – 0.78 – 0.82 –
 Shenzhen 0.80 0.79 0.87 0.87 0.76 0.77 0.85 0.86 0.73 0.78 0.79 0.80
Romania 0.82 0.83 0.93 0.94 0.90 0.90 0.95 0.95 0.89 0.89 0.93 0.94
South Africa 0.77 – 0.87 – 0.82 – 0.86 – 0.76 – 0.85 –
Ukraine 0.71 – 0.84 – 0.77 – 0.86 – 0.68 – 0.85 –
USA – 0.76 – 0.89 – 0.78 – 0.90 – 0.82 – 0.89
Total 0.76 0.80 0.88 0.89 0.80 0.82 0.89 0.91 0.80 0.84 0.86 0.88
1 The K6 asked respondents to rate how often they felt (1) nervous, (2) hopeless, (3) restless or fi dgety, (4) so depressed 
that nothing could cheer you up, (5) that everything was an effort, and (6) worthless over one of two recall periods: the 
past-month (the P columns in the table; respondents were asked to rate how often the symptoms occurred in the 30 days 
before the survey) and the worst-month (the W columns in the table; respondents are asked about the 30-day period 
during the past 12 months when they had the most severe psychological distress). The response options, which were 
identical in the two recall periods, were all of the time, most of the time, some of the time, a little of the time, and none 
of the time. Some WMH surveys used only one of these recall periods while others used both. This is why there are 
missing values in some cells of the table. The results in the total row are based on analysis of pooled within-country 
matrices that weight countries by the number of respondents in their samples rather than by their population sizes.
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Table 4 Severity parameters for the two-parameter worst-month Item Response Theory (IRT) model based on nested 
dichotomous scoring of the K6 in all countries combined
Frequency of symptom (How much of the time . . .)1
All Most Some A little
Nervous 2.4* 1.8* 1.1* 0.3*
Hopeless 2.3* 1.9* 1.4* 0.9*
Restless or fi dgety 2.4* 1.9* 1.2* 0.5*
So depressed that nothing could cheer you up 2.3* 1.9* 1.4* 1.0*
Everything was an effort 2.4* 1.8* 1.2* 0.6*
Worthless 2.3* 1.9* 1.5* 1.1*
* Signifi cant at the 0.05 level, two-sided test. Standard errors of parameter estimates are not reported, as each rounds 
to 0.0.
1 Coeffi cients are for dummy variables for the four response categories in comparison to the none of the time response 
category.
that are greater than 1.0 (van der Linden and Hambleton, 
1997). The K6 slopes were in the range 1.1–3.0 with a 
median of 1.8 and an inter-quartile range (25th to 75th 
percentiles) of 1.6–2.7. This means that scales based on 
one-parameter and two-parameter IRT models are very 
highly correlated (over 0.9 in each country).
The general pattern of IRT severity parameters can be 
seen by inspecting these parameters based on the two-
parameter IRT model for the worst month estimated in 
all the countries combined (Table 4). We see there that 
the severity estimates for responses of ‘none of the time’ 
(benchmarked at odds of 1.0 by construction) differ little 
from those for responses of ‘a little of the time’ (odds-
ratios of 0.3–1.1 across items) or ‘some of the time’ (1.1–
1.5), whereas the severity estimates for responses of ‘most 
of the time’ are considerably higher (1.8–1.9) and those 
for ‘all of the time’ are higher still (2.3–2.5). This means 
that a scoring scheme that gave especially high values to 
the highest two responses (e.g. 0,0,0,5,10) would do better 
than the unit-scoring scheme (i.e. 0,1,2,3,4) in maximiz-
ing inter-correlations among the six K6 items. It is not 
clear from this result, though, whether an alternative 
scoring scheme would be superior to the unit-weighting 
scheme in predicting SMI. We investigated this question 
next by comparing the strength of predictions based on 
versions of the K6 scale using unit weight versus IRT-
based weighting.
The regression analysis
A number of multiple regression equations were esti-
mated to predict DSM-IV/CIDI diagnoses of SMI in each 
country. Although we originally considered separate 
models for unweighted (i.e. unit weighting) and weighted 
(i.e. IRT-based weighting) K6 scores, these models
 turned out to be virtually identical because the weighted 
and unweighted K6 scores were found to be very highly 
correlated to each other in all countries. These correla-
tions were in the range 0.96–0.99 for past-month K6 for 
all countries. The correlations were all 0.99 for worst-
month K6. In countries where both past-month and 
worst-month K6 were assessed, the models based on these 
two different recall periods were also very similar because 
of high correlations between past-month and worst-
month K6 scores (0.78 in Japan, 0.87 in Brazil, and 0.92–
0.97 in the other countries that assessed the K6 in both 
recall periods).
A number of the total of 93 multiple regression equa-
tions were estimated to predict DSM-IV/CIDI diagnoses 
of SMI for each recall period assessed in each country. (As 
a result of the high correlation between unweighted and 
weighted K6 scores, all results reported below refer to the 
unweighted version that used 0–24 scoring.) The fi rst 
three models considered the K6 alone with either a linear, 
quadratic, or third-degree functional form (e.g. K6, 
K6-squared, and K6-cubed all in the same equation) in 
predicting SMI. A series of seven additional models for 
each of the three K6 functional forms then added socio-
demographic controls either one at a time, two at a time, 
or all three at once. Eight more complex models were then 
estimated that included two-way interactions among the 
socio-demographic variables either one at a time, two at 
a time, or all three at once and then added the three-way 
interaction among all the socio-demographics. The 
remaining models then added interactions of the K6 (with 
and without its successive polynomials) with the socio-
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demographics in each of the 15 lower-order socio-
demographic models.
As noted above in the section on analysis methods, 
comparative model fi t across these 93 equations was eval-
uated with the Akaike Information and Bayesian Infor-
mation criteria. In cases where these two measures led to 
different conclusions, we selected the less complex of the 
two preferred models. This resulted in a variety of differ-
ent models being selected across countries (Table 5). It is 
noteworthy that the quadratic term of the K6 was signifi -
cant in about half the surveys. The coeffi cient associated 
with the K6 was always positive and the coeffi cient associ-
ated with the K6-squared was always negative in these 
cases, indicating that the log-odds of SMI increased at a 
decreasing rate as the values of the K6 increased. Socio-
demographics were signifi cant in 11 surveys and interac-
tions among socio-demographics in eight surveys. These 
signifi cant coeffi cients indicate that The K6 does not 
explain socio-demographic differences in SMI in most 
countries, a pattern that could be due either to a lack of 
reliability of the K6 or to systematic differences in the 
extent to which the K6 detects the kinds of disorders 
responsible for SMI in these different segments of the 
population.
Differential sensitivity would be indicated by interac-
tions between K6 scores and the socio-demographics in 
predicting SMI. These interactions were signifi cant in 
only fi ve surveys (in Colombia, Lebanon, Nigeria, India, 
and the USA). Signifi cant interactions were found with 
gender in four of these fi ve countries, all involving stron-
ger associations between K6 scores and SMI among 
women than men. Signifi cant interactions were also 
found with age and education, but they were inconsistent 
in sign across countries. Inclusion of main effects and 
interactions involving these socio-demographic variables 
with K6 scores corrected for bias that would otherwise 
have occurred in estimating individual-level predicted 
probabilities of SMI. With these corrections in the models, 
the AUC values were generally substantial, with the 
median value of AUC across countries equal to 0.83, the 
Table 5 Signifi cant model parameters of best-fi tting regression models to predict DSM-IV/CIDI SMI from K6 scores1
K6 K62 K63 SD SD × SD K6 × SD
Brazil X X X
Bulgaria X X X X
Colombia X X X X X
India X X X
Japan X
Lebanon X X X X X
Mexico X X X
New Zealand X X X X
Nigeria X X X
People’s Republic of China
 Beijing/Shanghai X X X
 Shenzhen X
Romania X X X
South Africa X
Ukraine X X X X
USA X X X X X
Total
1 Signifi cant parameters are indicated by an X. Only a general summary is presented here. See the appendix tables 
(available at http://www.hcp.med.harvard.edu/wmh/publications.php) for a description of exact parameters and parameter 
values. Due to the high correlations between past-month and worst-month K6 scores in countries that used both recall 
periods, the coeffi cients found to be signifi cant were identical for past-month and worst-month models in these countries. 
The entries for K6, K62 and K63 represent the signifi cance of the main effects of these three transformations of the K6 
scale. The entry for SD represents the signifi cance of one or more main effects of socio-demographic (SD) variables. 
The entry for SD × SD represents the signifi cance of one or more interactions among the socio-demographic variables. 
The entry for K6 × SD represents the signifi cance of one or more interactions between the K6 (or its polynomials) and 
one or more socio-demographic variables (or interactions among socio-demographic variables).
Kessler et al. K6 screening scale for SMI
Int. J. Methods Psychiatr. Res. 19(Supplement 1): 4–22 (2010). DOI: 10.1002/mpr
Copyright © 2010 John Wiley & Sons, Ltd 17
range 0.76–0.89, and the inter-quartile range 0.81–0.85 
(Table 6). These high AUC support the use of the equa-
tions to generate individual-level estimates of predicted 
probability of SMI in all countries in both time frames.
Discussion
The results presented here show that relatively simple 
optimal scoring rules can be developed for the K6 in all 
the countries studied that generate predicted probabilities 
of SMI having substantial concordance with observed 
ratings of DSM-IV SMI based on the CIDI. It is striking 
that responses to a simple set of six questions, which take 
no more than 2 minutes to administer, can reproduce 
with such good accuracy diagnostic ratings based on a 
fully structured research diagnostic interview that takes 
an average of more than 1 hour to administer. This result 
argues that the K6 can be a valuable screening scale for 
SMI in general-purpose epidemiological surveys where it 
is not feasible to include a long assessment of mental 
disorders like the CIDI. Other validated screening scales 
exist to screen for specifi c mental disorders, such as the 
PHQ-9 screening scale of major depression (Kroenke 
et al., 2001) and the ASRS screening scale of adult 
attention-defi cit/hyperactivity disorder (Kessler et al., 
2005a). When the purpose of a particular research study 
is to investigate patterns and correlates of specifi c disor-
ders, more specifi c screening scales such as these should 
be preferred to the K6. However, SMI is associated with a 
wide range of different mental disorders and it is impor-
tant to have a more general screening scale for SMI such 
as the K6 when the researcher is more interested in screen-
ing broadly for SMI than for a particular kind of 
disorder.
It is important in this context to recognize that while 
the value of the K6 is as a broad screener rather than a 
specifi c screener for any one mental disorder, a limitation 
of the K6, as of the concept of SMI itself, is that the spe-
cifi c policy implications for treatment planning purposes 
of documented trends or correlates can be determined 
only by carrying out further analyses of component dis-
orders. To some extent, of course, the same criticism can 
be made even of screening scales for more specifi c disor-
ders, as it might be that some sub-types of specifi c disor-
ders are more strongly related than others with correlates. 
However, as treatment approaches are much more similar 
within than between mental disorders, it remains true 
that policy implications of results regarding correlates of 
SMI are less clear than those regarding correlates of 
specifi c disorders.
Another limitation of the K6 is that, despite showing 
substantial concordance with an independent measure of 
SMI based on research diagnostic interviews, the number 
of items in the scale is so small that they might not span 
the full conceptual space that defi nes SMI in the popula-
tion, leading to less sensitivity in detecting some types of 
SMI than others. This would not be a concern if AUC was 
perfect, but it is not. An AUC of 0.85, while very good, 
still means that 15% of true cases of SMI are not detected 
by the screening scale. If this under-detection is system-
atic (i.e. concentrated in a particular type of mental dis-
order in a specifi c segment of the population) rather than 
random, then even a dramatic increase in the component 
of SMI systematically missed by the scale will not be 
detected in trend surveys. Because of this possibility, it is 
important to carry out a second generation of method-
ological studies of the K6 now that its overall validity has 
been documented. These second-generation studies 
should search for evidence of systematic bias. We know 
from the analyses carried out here that biases with respect 
to age, gender, and education are minimal and that the 
scale has good properties across a wide range of countries, 
but we are aware of no comparable attempt to study bias 
with respect to other socio-demographic variables or with 
respect to specifi c types of mental disorders.
Table 6 Area under the receiver operating characteristic 
curve (AUC) for the best-fi tting model of the association 










New Zealand 0.81 0.88
Nigeria 0.82 –
People’s Republic of China
 Beijing/Shanghai 0.85 –
 Shenzhen 0.84 0.86
Romania 0.78 0.80
South Africa 0.76 –
Ukraine 0.83 –
USA – 0.89
1 Missing values are because some surveys used only one 
of the two recall periods.
K6 screening scale for SMI Kessler et al.
 Int. J. Methods Psychiatr. Res. 19(Supplement 1): 4–22 (2010). DOI: 10.1002/mpr
18 Copyright © 2010 John Wiley & Sons, Ltd
A fi nal noteworthy limitation is that the optimal 
scaling rules developed here and reported in the appendix 
tables (available at http://www.hcp.med.harvard.edu/
wmh/publications.php) are known to be optimal only 
with respect to the WMH surveys in which the rules were 
developed. This point was made in the Introduction, but 
needs to be reiterated here: that it is always preferable to 
base scaling rules whenever possible on clinical calibra-
tion studies embedded in the very same data collection 
that is used to administer the screening scale. This is the 
only way to guarantee that the sensitivity, specifi city, and 
positive predictive value of the screening scale in the 
population under study are identical to those in the cali-
bration sample. As described elsewhere is this issue (Colpe 
et al., 2010), the US Substance Abuse and Mental Health 
Services Administration (SAMHSA) is addressing this 
problem by initiating an ongoing K6 calibration compo-
nent in its annual National Household Survey on Drug 
Use and Health (NHSDUH). In this approach, a probabil-
ity sub-sample of NHSDUH respondents that over-
samples those with high K6 scores is administered a 
clinical re-interview to assess the presence of SMI. Clini-
cal interviewers are blinded to the K6 responses in the 
main survey. This allows the SAMHSA investigators to 
calibrate K6 scores to predicted probabilities of SMI on 
an ongoing basis so as to protect against the possibility 
that the sensitivity and positive predictive value of the K6 
decrease over time. Such decreases could be the result 
either of an increase in the relative importance of types 
of mental disorders that are not sensitively detected in the 
K6 in making up the total number of people with SMI or 
of secular changes in the words people use to describe 
their mental disorders. In any case, where the K6 is used 
as a screening scale in some other country in a large 
ongoing survey like the NHSDUH, it could be of consid-
erable valuable to include an ongoing clinical calibration 
component of this sort. Not only will this allow the 
formula to estimate predicted probability of SMI from K6 
scores to be modifi ed over time to correct for secular 
changes in concordance, but the accumulation of more 
and more clinical cases over time will make it possible to 
refi ne calibration rules successively to capture subtle dif-
ferences in concordance among respondents who differ 
in other characteristics assessed in the survey.
The question arises how to make best use of predicted-
probability data in analysing transformed K6 scores. 
Several methods exist to do this. One is to treat the mean 
predicted probability as the variable of interest in linear or 
restricted linear (e.g. Tobit) prediction equations. Another 
possibility is to generate actual yes–no classifi cations of 
SMI for each respondent based on their predicted 
probabilities and then to analyse the data as one would 
with any other dichotomous diagnostic measure. There 
are two ways to do this that yield equivalent results. One 
is to use the predicted probabilities as weights. Under this 
approach, a respondent assigned a 0.25 predicted proba-
bility of SMI is treated as two people, one a person with a 
weight of 0.25 who has SMI and the other a person with a 
weight of 0.75 who does not have SMI. More generally, the 
observational record for each respondent is reproduced so 
that the sample is treated as having twice as many observa-
tions as it actually has, one for each respondent coded as 
having SMI and the other as not, with the pair of observa-
tions for each respondent having a sum of weights of 1.0 
(or, in the case of otherwise weighted data, with the sum 
of weights equal to whatever the sample weight would 
otherwise have been for the respondent). The relative 
weighting of the two data records in each pair varies across 
respondents depending on the respondent’s predicted 
probability of SMI. The MI estimation method described 
earlier in the paper can be used here by applying this 
weighting approach separately to each of the separate MI 
datasets and then pooling coeffi cients across pseudo-
samples using standard MI methods (Rubin, 1987).
A more parsimonious alternative to the above approach 
that does not require the number of records to be doubled 
is to classify each respondent either as having or not 
having SMI by using a random number generator from a 
binomial distribution that is defi ned by the respondent’s 
own predicted probability of SMI from the imputation 
equation. For example, if a random number was selected 
between 1 and 100 for a respondent with a predicted 
probability of SMI of 0.25, the respondent would be clas-
sifi ed as having SMI if the random number was in the 
range 1–25 and as not having SMI if the random number 
was in the range 26–100. A separate random number 
would then be selected independently for each other 
respondent such that the respondent would be classifi ed 
as having SMI if the random number was less than or 
equal to 100 times the respondent’s predicted probability 
of SMI and classifi ed otherwise as not having SMI. The 
dichotomous outcomes generated in this way can be ana-
lysed in the same way as any other dichotomous diagnos-
tic variable. In addition, MI can again be implemented by 
repeating the entire process for each of the individual’s 
SMI prevalence estimates (importantly, selecting a new 
random number for each respondent for the estimated 
probability of SMI based on each separate pseudo-sample, 
not using a single predicted probability for a given indi-
vidual across all pseudo-samples) and using conventional 
MI methods to analyse and combine results across the 
separate pseudo-samples.
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